1 interaction related to latuda
Lurasidone is primarily metabolized by CYP3A4 and is highly sensitive to CYP3A4 inhibitors. The FDA-approved Latuda prescribing information specifically states that grapefruit and grapefruit juice should be avoided in patients taking lurasidone because they inhibit CYP3A4 and can substantially raise lurasidone concentrations.